Investigational drugs reduce risk of death from Ebola virus disease

The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease (EVD) compared to the investigational treatment ZMapp, according to published results from a clinical trial conducted in the Democratic Republic of the Congo (DRC). The new report al …
Ingeniería
Enlace: Investigational drugs reduce risk of death from Ebola virus disease